MDxHealth News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.12.23	MDxHealth Announces Completion of Transition to Single Listing on Nasdaq (GlobeNewswire)
27.11.23	MDxHealth Announces Completion of Mandatory ADS Exchange and Commencement of Transition Period to Single Listing on Nasdaq (GlobeNewswire)
14.11.23	MDxHealth to Participate in the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
13.11.23	MDxHealth Announces Completion of Share Consolidation, and Update of Outstanding Shares and Voting Rights (GlobeNewswire)
08.11.23	MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2023 (GlobeNewswire)
06.11.23	MDxHealth Announces the Approval by its Shareholders of the Proposed Transition to a Sole Listing of Shares on Nasdaq, and Details of the Share Consolidation (GlobeNewswire)
25.10.23	MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8 (GlobeNewswire)
20.10.23	Mdxhealth's New Share Capital Amount and New Number of Shares (GlobeNewswire)
09.10.23	MDxHealth Reports Preliminary Q3-2023 Revenues (GlobeNewswire)
02.10.23	MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting (GlobeNewswire)
26.09.23	Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer (GlobeNewswire)
23.08.23	MDxHealth Reports Q2 and Half Year 2023 Results (GlobeNewswire)
10.08.23	MDxHealth to Present Q2 and Half Year 2023 Financial Results and Corporate Update on August 23 (GlobeNewswire)
09.08.23	Cigna Expands Commercial and Medicare Advantage Coverage to Include Mdxhealth’s Select mdx for Prostate Cancer Test (GlobeNewswire)
30.06.23	MDxHealth Announces Results of its Extraordinary General Shareholders’ Meeting (GlobeNewswire)
05.06.23	MDxHealth Announces its Extraordinary General Shareholders’ Meeting (GlobeNewswire)
25.05.23	MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings (GlobeNewswire)
23.05.23	MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference (GlobeNewswire)
15.05.23	MDxHealth Reports Q1-2023 Results (GlobeNewswire)
01.05.23	MDxHealth to Present First Quarter 2023 Financial Results on May 15 (GlobeNewswire)
25.04.23	MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings (GlobeNewswire)
19.04.23	Foundational LCD Covers Select mdx for Prostate Cancer (GlobeNewswire)
07.04.23	MDxHealth Shareholder Transparency Declaration (GlobeNewswire)
13.03.23	MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank (GlobeNewswire)
08.03.23	MDxHealth Announces Update of Outstanding Shares and Voting Rights (GlobeNewswire)
08.03.23	MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023 (GlobeNewswire)
06.03.23	MDxHealth Announces Exercise of Option (GlobeNewswire)
03.03.23	MDxHealth Shareholder Transparency Declarations (GlobeNewswire)
28.02.23	MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference (GlobeNewswire)
22.02.23	MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 (GlobeNewswire)
21.02.23	MDxHealth Shareholder Transparency Declaration (GlobeNewswire)
15.02.23	MDxHealth Announces Update of Outstanding Shares and Voting Rights and Update of Financial Calendar (GlobeNewswire)
13.02.23	MDxHealth Announces UnitedHealthcare to Provide Commercial Coverage for the Genomic Prostate Score (GPS) Test (GlobeNewswire)
22.11.21	MDxHealth Shareholder Transparency Declarations (GlobeNewswire)
15.11.21	MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States (GlobeNewswire)
08.11.21	MDxHealth Announces Completion of Initial Public Offering of ADSs in the United States (GlobeNewswire)
04.11.21	MDxHealth Announces Pricing of Initial Public Offering of ADSs in the United States (GlobeNewswire)
28.10.21	MDxHealth Announces Launch of Proposed Initial Public Offering of ADSs in the United States (GlobeNewswire)
21.10.21	MDxHealth Provides Q3-2021 Business Update (GlobeNewswire)
13.10.21	MDxHealth files Registration Statement for Proposed Initial Public Offering in the United States (GlobeNewswire)
01.09.21	MDxHealth Announces Submission of Draft Registration Statement For Proposed Public Listing in the United States (GlobeNewswire)
26.08.21	MDxHealth Reports Half Year 2021 Results (GlobeNewswire)
12.08.21	MDxHealth to Present First Half 2021 Financial Results and Corporate Update on August 26 (GlobeNewswire)
21.05.21	MDxHealth Announces Favorable Draft Medicare Coverage for the SelectMDx for Prostate Cancer Test (GlobeNewswire)
27.04.21	MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings (GlobeNewswire)
21.04.21	MDxHealth Provides Q1-2021 Business Update (GlobeNewswire)
15.05.20	MDxHealth Completes the Equity Investment by MVM Partners (GlobeNewswire)
28.04.20	MDxHealth Announces its Annual and Extraordinary General Shareholders’ Meetings (GlobeNewswire)
26.02.20	MDxHealth Reports Financial Year 2019 Results and Provides Outlook for 2020 (GlobeNewswire)
02.09.18	MDxHealth (MDXH-BR): Building Momentum (EQS Group)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu MDxHealth SA

Aktien Top/Flop

Meistgelesene Nachrichten